B06 Other hematological agents
ATC group of level 2 – therapeutic subgroup · in plain English: other medicines for the blood
This site has the patient leaflet or the SPC of 24 medicines in this group and its subgroups.
- 15 prescription only (POM)
- 6 no longer supplied or not available
Place in the ATC classification
- B Blood and blood forming organ drugs 1,013 medicines
-
B06 Other hematological agents 24 medicines
- B06A Other hematological agents 24 medicines
-
B06 Other hematological agents 24 medicines
Active substances in the group
- Autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene 1 medicine
- Berotralstat 1 medicine
- C1 ESTERASE INHIBITOR HUMAN 6 medicines
- Conestat alfa 3 medicines
- Crizanlizumab 1 medicine
- Hyaluronidase 1 medicine
- Icatibant 6 medicines
- Lanadelumab 4 medicines
Medicines in the group and its subgroups
Other groups of the same level
- B01 Antithrombotic agents 447 medicines
- B02 Antihemorrhagics 196 medicines
- B03 Antianemic preparations 152 medicines
- B05 Blood substitutes and perfusion solutions 194 medicines
Other names of the ATC group
- Czech: B06 Jiné hematologické látky
- French: B06 autres médicaments utilisés en hématologie
- German: B06 ANDERE HÄMATOLOGIKA
- German: B06 ANDERE HÄMATOLOGIKA
- Italian: B06 Agenti ematologici
- Polish: B06 Inne substancje hematologiczne
- Turkish: B06 ATC'DEKİ DİĞER HEMATOLOJİK AJANLAR
- Portuguese (Brazil): B06 OUTROS AGENTES HEMATOLÓGICOS
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group B06
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
